 |
Previous Article | Next Article 
Journal of Neuroscience, Vol 6, 274-280, Copyright © 1986 by Society for Neuroscience
Electrophysiological evidence for the existence of both D-1 and D-2 dopamine receptors in the rat nucleus accumbens
FJ White and RY Wang
Extracellular single-unit recording and microiontophoretic techniques were
used to characterize the pharmacological properties of dopamine (DA)
receptors within the rat nucleus accumbens (NAc), a forebrain structure
that receives a dense innervation from mesolimbic DA- containing neurons
(A10 DA neurons) located in the ventral tegmental area (VTA). Of the NAc
neurons tested, 75% were inhibited by microiontophoretic administration of
the selective D-2 receptor agonist, LY-141865, whereas 38% were inhibited
by microiontophoretic administration of the selective D-1 receptor agonist,
SKF-38393. Of the 30 NAc neurons that were tested with both of these
agonists, nine were inhibited by both agonists, 11 were inhibited only by
LY-141865, five were inhibited only by SKF-38393, and five were not
affected by either of these compounds. The inhibitory effects of LY-141865
were blocked and reversed by either intravenous or iontophoretic
administration of the selective D-2 antagonist (-)-sulpiride, which,
however, failed to alter the inhibitory effects of SKF-38393. In contrast,
the purportedly selective D-1 antagonist, SCH-23390, selectively blocked
and reversed the inhibitory effects of SKF-38393, suggesting that the two
agonists were producing their inhibitory effects via distinct DA receptors.
Additional experiments indicated that intravenous administration of LY-
141865 caused a biphasic increase/decrease in the activity of NAc neurons.
The initial rate increase was apparently due to disinhibition since it was
also shown that D-2 DA receptors located on A10 DA neurons exhibited a
3-10-fold greater sensitivity to LY-141865 and DA as compared to the NAc
D-2 receptors.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:

|
 |

|
 |
 
M. F. Perez, F. J. White, and X.-T. Hu
Dopamine D2 Receptor Modulation of K+ Channel Activity Regulates Excitability of Nucleus Accumbens Neurons at Different Membrane Potentials
J Neurophysiol,
November 1, 2006;
96(5):
2217 - 2228.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Brady and P. O'Donnell
Dopaminergic Modulation of Prefrontal Cortical Input to Nucleus Accumbens Neurons In Vivo
J. Neurosci.,
February 4, 2004;
24(5):
1040 - 1049.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Yasumoto, E. Tanaka, G. Hattori, H. Maeda, and H. Higashi
Direct and Indirect Actions of Dopamine on the Membrane Potential in Medium Spiny Neurons of the Mouse Neostriatum
J Neurophysiol,
March 1, 2002;
87(3):
1234 - 1243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. B. Floresco, C. D. Blaha, C. R. Yang, and A. G. Phillips
Dopamine D1 and NMDA Receptors Mediate Potentiation of Basolateral Amygdala-Evoked Firing of Nucleus Accumbens Neurons
J. Neurosci.,
August 15, 2001;
21(16):
6370 - 6376.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. B. Floresco, C. D. Blaha, C. R. Yang, and A. G. Phillips
Modulation of Hippocampal and Amygdalar-Evoked Activity of Nucleus Accumbens Neurons by Dopamine: Cellular Mechanisms of Input Selection
J. Neurosci.,
April 15, 2001;
21(8):
2851 - 2860.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Druhan, C. L. Walters, and G. Aston-Jones
Behavioral Activation Induced by D2-Like Receptor Stimulation during Opiate Withdrawal
J. Pharmacol. Exp. Ther.,
August 1, 2000;
294(2):
531 - 538.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Ikemoto, B. S. Glazier, J. M. Murphy, and W. J. McBride
Role of Dopamine D1 and D2 Receptors in the Nucleus Accumbens in Mediating Reward
J. Neurosci.,
November 1, 1997;
17(21):
8580 - 8587.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-X. Shi, P. L. Smith, C.-L. Pun, B. Millet, and B. S. Bunney
D1-D2 Interaction in Feedback Control of Midbrain Dopamine Neurons
J. Neurosci.,
October 15, 1997;
17(20):
7988 - 7994.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Koob and F. Bloom
Cellular and molecular mechanisms of drug dependence
Science,
November 4, 1988;
242(4879):
715 - 723.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Walters JR, D. Bergstrom, J. Carlson, T. Chase, and A. Braun
D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects
Science,
May 8, 1987;
236(4802):
719 - 722.
[Abstract]
[PDF]
|
 |
|
|